Study design:

Randomized clinical trial 

Sample size: 

300 participants 

Study Sites

Rigshospitalet, Bispebjerg Hospital, Odense University Hospital, Aalborg University Hospital.

Inclusion criteria

Adult high-risc patients (from 18 years of age) acutely admitted with i.e. sepsis, dyspnea, heart failure, ACS or pneumonia. 

Study Procedures

Included patients will be monitored with WARD equipment after hospital admission and will be monitored during hospitalization. Patients will be randomized to receive either standard treatment where WARD study-data are blinded to the healthcare professionals (nurses etc.) treating the patient (control group) or will have real-time continuous monitored vital parameter data transferred to an alarm-generating App (WARD-CSS) in case of vital parameter deviations, that the nurse responsible for the patient care can access through a provided WARD smartphone (case group).

Outcome